Oct 23 2015
3:30 PM - 5:30 PM
Marriott Wardman Park, Washington, D.C.

Buchanan FDA Shareholder William A. Garvin spoke at the AIPLA 2015 Annual Meeting's Committee Educational Session. His session, titled "Biosimilars are Off and Running: A Litigation and Regulatory Update," explored what can be gleaned about the regulatory pathway from the approvals to date, as well as the latest litigation developments.

Learn more about the event here.